malignant mesothelioma mortality
A British medical journal, The Lancet, revealed the disturbing results of a study found no benefit of chemotherapy in patients with pleural mesothelioma malignant (MPM).
The research, seen as a setback for scientists seeking treatment for the condition, was conducted by Nicholas J. Vogelzang, MD, director of the Nevada Cancer Institute in Las Vegas and was released in May 2008.
The ineffective treatment of chemotherapy Mesothelioma
The study found that chemotherapy not only offers no improvement among patients with mesothelioma but was found to have no significant impact whatsoever on the rate of survival of victims.
According to the study, the average median survival rate among victims who received an active symptom control (ASC) compared to those receiving the same treatment plus chemotherapy was less than a month apart, suggesting a beneficial impact, although the study suggested further research into treatments and chemotherapy ASC that is needed.
What is malignant pleural mesothelioma?
MPM is considered as an advanced and more serious form of malignant mesothelioma and has been characterized as an aggressive tumor with poor prognosis, according to a study published in The Oncologist, a magazine International Medical in 2007. The cancer usually affects the lungs of a person and causes serious breathing difficulties.
The condition is also difficult to treat due to the high rate of diagnostic errors in patients. Unfortunately, the incidence of this condition has also been increasing, and experts speculate that in the next 10 to 20 years, the number will rise.
Mesothelioma Causes
For years, mesothelioma has been associated with inhalation asbestos fibers and vermiculite dust. Vermiculite is a mineral that was heavily mined. During the 20th century, several mines vermiculite, although the exact number is unknown, were functional in the U.S., with a host of other mines in operation worldwide.
Environment Protection Agency (EPA) is currently in charge of regulating and issuing guidelines for safe disposal and cleanup of asbestos in homes and building around the country. However, there is a large numbers, although estimates are not clear, of structures with asbestos insulation currently mounted in the United States and inadequate exposure to these may increase the risk of developing a form of mesothelioma.
Additional malignant mesothelioma treatment options
While the sad truth is that malignant pleural mesothelioma not usually fatal among the victims, there are few treatment options for disease management, however, they often depend on the symptoms and disease stage.
Surgery is the most common treatment for mesothelioma, although a study published in July 2007 in The Oncologist emphasized that the role of surgery in the management of MPM is debatable. However, the three main surgical techniques used to manage MPM are pleurodesis, pleurectomy / decorication (P / D) and extrapleural pnemonectomy (PPE).
The study noted that so far, there have been no controlled studies to determine whether a surgical procedure is better than another. Surgical procedures, the P / D and EPP objective methods for local control of disease and while P / D has a limited morbidity, PPE is between 1.5 to 5 percent mortality.
It is often recommended that people who suffer from this type of mesothelioma or any other way to locate a mesothelioma lawyer mesothelioma with experience. Because of high costs and technical difficulties associated with the treatment of mesothelioma, a mesothelioma lawsuit can potentially provide relief in the form monetary compensation, especially since mesothelioma is considered by some to have been highly preventable.
About the Author:
Learn more about mesothelioma and other various treatments at http://mesothelioma.legalview.com/. Also, visit the LegalView homepage and peruse the extensive library of legal issues such as the Levaquin side effects or the Digitek digoxin recall or visit the revamped brain injury portal at http://brain-injury.legalview.com/.
Article Source: ArticlesBase.com – Recent Research Suggests Chemotherapy Ineffective for Mesothelioma Victims
Malignant Mesothelioma Mortality In United States 1999-2005
